<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EEA90A41-FE78-4648-A169-978B7D07858E"><gtr:id>EEA90A41-FE78-4648-A169-978B7D07858E</gtr:id><gtr:firstName>Assan</gtr:firstName><gtr:surname>Jaye</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081958"><gtr:id>955A0868-D8CC-49E5-8916-6FAC296EC94E</gtr:id><gtr:title>Comparison of Natural Killer cells functions in HIV-1 and HIV-2 infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081958</gtr:grantReference><gtr:abstractText>The worldwide AIDS pandemic is largely caused by one HIV strain called HIV-1, which after a variable length of time leads to AIDS and death in most infected people. There is a second HIV strain called HIV-2, which is mostly found in West Africa. This virus behaves quite differently from HIV-1: some HIV-2-infeceted people develop AIDS just as if they had HIV-1 but others, as many as 80%, have a normal lifespan and die of old age instead. Certain cells in the immune system, so called Natural Killer (NK) cells constitute the initial immune defence reaction against variety of viruses, fungi, parasites and bacteria.We want to see how an increase in the activity of these cells early in HIV-2 infection may be associated with progression to disease.</gtr:abstractText><gtr:technicalSummary>Natural Killer (NK) cells constitute the initial immune defence reaction against variety of viruses, fungi, parasites and bacteria. Their instant cytolytic activity against infected cells together with cytokines secretion to enhance adaptive immune response may indicate their significance in controlling infections. An increase in NK functional activity early in HIV infection may form the basis of a protracted stable CD4 T cells counts in HIV-2. We therefore compared cell numbers, lytic activity, IFNg release and chemokine production of NK cells in HIV-2 infected subjects who are matched by CD4 cell count.Peripheral blood mononuclear cells (PBMC) were obtained from 30 HIV-1 and 30 HIV-2 subjects each of 3 categories of CD4 counts (&amp;gt;500, 200-500, and 200 cells/ul) and 50 HIV uninfected control subjects. The results showed a similar frequency of NK cells in both HIV-1 and HIV-2 at CD4 counts &amp;gt; 200 cells/ul but was significantly lower in HIV-2 than in HIV-1subjects at CD4 counts &amp;lt;200 cells/ul (P&amp;lt;0.05). The frequency of NK cells in both infections was similar to HIV uninfected controls at CD4 counts &amp;gt;500cells/ul but was significantly lower at CD4 counts &amp;lt;500 cells/ul (P&amp;lt;0.05). There was a positive correlation between the CD4 T and NK cells in both infections. The cytotoxic response by NK cells was significantly higher in HIV-2 than in HIV-1 infections at CD4 count &amp;gt;500 cells/ul (p&amp;lt;0.05) and was similar to that of the healthy controls. There was significant correlation between cytolytic activity of NK cells and the frequency in HIV-2 individuals (r=0.59, p=0.001) and was inversely correlated to plasma viral load (r=-0.27, p=0.009). Interferon-g secretion by NK cells in ELISPOT assay was found to be of similar levels in HIV-1 and HIV-2 infections at all categories of CD4-T cell counts but was significantly lower as compare with HIV uninfected control (p&amp;lt;0.05).The Mip1b, RANTES, TNF-a and intracellular IFN-g from NK CD56bright cells were significantly higher in HIV-2 individuals than HIV-1 individuals at high CD4 counts of &amp;gt;500 cells/ul (p&amp;lt;0.05). However, MIP-1a secreting cells were similar in individuals of both infections. There were no significant differences in CD56dim cells producing these chemokines and cytokines in both infections (p&amp;gt;0.05). It is likely the efficient cytolytic activity and cyto/chemokine secretion early in HIV-2 infection may be associated with slow progression to disease. The enhancement of these functions may serve as basis in immunologically controlling HIV disease. Efforts are underway to characterise the Inhibiting and activation receptors of NK cells in both infections.</gtr:technicalSummary><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-02-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>250809</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Open days for public visits</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>2D06A01A-5F93-4B8F-8C5F-5BBC7760EE1D</gtr:id><gtr:impact>MRC open Days in which Poster presentations of MRC activities and outputs are showcased to public including schools, and policy makers

Increasing awareness of MRC's activities in the Gambia and strenthening relationship with the public it is working with.</gtr:impact><gtr:outcomeId>05063DBB37C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EGPAF International Leadership Award</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)</gtr:fundingOrg><gtr:id>F0B7279E-A836-435A-BFEB-168BAB82CBEE</gtr:id><gtr:outcomeId>39B8D9735040</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4BBAB7D6-0556-405A-B9E2-9D3EF14154F2</gtr:id><gtr:title>Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/665d17a793c5b72eb49a1e5abaa3d19e"><gtr:id>665d17a793c5b72eb49a1e5abaa3d19e</gtr:id><gtr:otherNames>Nuvor SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>B9B1CAF01C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DE9FA73-DA4B-44DD-A964-8453B6FE5D32</gtr:id><gtr:title>Polyfunctional T cell responses are a hallmark of HIV-2 infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f90a66fcd9ab2ce6df6436b14b4eb6d"><gtr:id>6f90a66fcd9ab2ce6df6436b14b4eb6d</gtr:id><gtr:otherNames>Duvall MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>749A0BB60CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F48E6E9-85BC-4EFB-A182-6779B23D9C60</gtr:id><gtr:title>Differential Expressions of Selected Activating and Inhibitory Receptors on K562-Stimulated Natural Killer (NK) Cells in HIV-1 and HIV-2 Infections</gtr:title><gtr:parentPublicationTitle>World Journal of AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/964984be69e6740c853d15cba8a5b661"><gtr:id>964984be69e6740c853d15cba8a5b661</gtr:id><gtr:otherNames>V. Nuvor S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e06628cb4550.87915006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91CBC16C-6A20-4C98-8667-0B2BEB36D6F2</gtr:id><gtr:title>Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f90a66fcd9ab2ce6df6436b14b4eb6d"><gtr:id>6f90a66fcd9ab2ce6df6436b14b4eb6d</gtr:id><gtr:otherNames>Duvall MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>10435A9EAB1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF5A8ECB-AA84-4A60-97EA-A84F86F781C4</gtr:id><gtr:title>Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f90a66fcd9ab2ce6df6436b14b4eb6d"><gtr:id>6f90a66fcd9ab2ce6df6436b14b4eb6d</gtr:id><gtr:otherNames>Duvall MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>77E540EECC6</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081958</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>